GI & Endoscopy

Researchers Identify Glycan Fingerprint for Stomach Cancer Risk in H. pylori Patients

In a recent study published in Cancer Prevention Research, researchers identified a serum glycan that has the potential to serve a diagnostic tool that would differentiate between patients with gastric cancer and patients with non-atrophic gastritis.

Carrie Pallardy

Monday, January 6th, 2014

Of those that have a Helicobacter pylori infection, one to three percent develop stomach cancer. The serum glycan could serve to identify patterns that indicate an early biomarker of gastric cancer.

More Articles on Gastroenterology:
14 Colonoscopy Quality Indicators to Consider
ASGE Announces New 2014 Training Courses
10 Most-Read Stories on Gastroenterology

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a…

By: Sophie Eydis
Thursday, January 15th, 2026
Gastroenterologist pay breakdown in 10 stats

As of Dec. 14, gastroenterologists’ average annual salary is $583,380, according to salary transparency platform Marit Health’s compilation of 215…

By: Patsy Newitt
Thursday, January 15th, 2026
5 GI leaders on what’s changing in colonoscopy

Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built…

By: Patsy Newitt
Thursday, January 15th, 2026

Comments are closed.

Recoupments 101: The biggest RCM problem no one’s talking about

Next Up in GI & Endoscopy

FDA clears final trial stage for robotic GI surgery system

Gastroenterologist pay breakdown in 10 stats

5 GI leaders on what’s changing in colonoscopy

Join the 40,000+ ASC leaders who start their day with Becker's